- Raising Capital at AFSIC: an unparalleled opportunity to connect with the top DFIs and PE
- US Tariffs: How are Emerging Markets Managers Positioned?
- India’s Waqf Policy Shift: How AI Can Drive Transparency & Growth
- Fitch: Nigerian Bank Ratings Sensitive to Sovereign, Operating Environment
- Shaping the Future of Banking in Southern Africa: Innovation, Connectivity, and Financial Resilience
Nigeria Best Stock Performer Sees `Huge’ Growth on Vaccines
LAGOS (Capital Markets in Africa) – May & Baker Nigeria Plc, which is establishing Nigeria’s sole vaccine-production facility in a partnership with the government, said it expects sales to soar when it starts manufacturing them within two years due to a shortage of supply in the region. “There is a huge potential for May & Baker,” Chief Executive Officer Nnamdi Okafor, 56, said in an interview in Lagos, Nigeria’s commercial capital. Revenue for the nation’s second-biggest pharmaceutical…
Read More